Skip to main content
. 2020 Dec 17;12(12):3853. doi: 10.3390/nu12123853

Table 5.

Effects of isoflavones in menopausal symptoms.

Authors Number of Studies Included Type of Studies Included Number of Participants and Gender/Age/Characteristics Compound and Doses Observed Effects
Meta-analysis
Chen et al., 2015 [86] 15 RCT 30–252 perimenopausal or postmenopausal women/report (1753 in total)
49–58.3 years (placebo group)
48–60.1 years (phytoestrogen group)
Isoflavones 5–100 mg/day
Intervention period: 3–12 months
Reduction of hot flush frequency (vs. placebo)
Li et al., 2015 [87] 16 RCT 24–236 women/report (median 90)
40–65 years
Soy isoflavones 30–200 mg/day
Intervention period: 4 weeks–2 years (median 12 weeks)
Slight and slow attenuation of hot flushes (vs. estradiol)
Li et al., 2016 [88] 39 RCT 24–620 women/report (median 200)
Age not available
SSRIs/SNRIs: 7.5–200 mg/day
Gabapentin: 300–1800 mg/day
Clonidine: 0.1–0.4 mg/day
Soy isoflavones: 30–200 mg/day
Intervention period: 2–96 weeks (average 12 weeks)
Slight and slow attenuation of hot flushes (vs. non-hormonal drugs)
Daily et al., 2019 [85] 5 RCT 728 menopausal women (total subjects)
50.5–58.8 years (mean)
Soy isoflavones: 33–200 mg/day and 6 g soy extract/day
Equol: 10 mg/day
Intervention period: not available
Equol or isoflavone in equol-producers more effective than placebo
Sarri et al., 2017 [89] 32 RCT 4165 menopausal women (total subjects)
45+ years
Isoflavones and black cohosh
(Doses not available)
Reduction of VSM (hot flushes and night sweats) compared to placebo
No beneficial effect (vs. pharmacological treatment)
Franco et al., 2016 [90] 17 RCT 30–252 women/trial
40–69 years
Dietary soy isoflavones: 42–90 mg/day
Supplements and extracts of soy isoflavones: 10–100 mg/day
Red clover: 40–160 mg/day
Intervention period: 12–48 weeks
Reduction of hot flush frequency by means of dietary isoflavones and supplements)
Reduction of night sweat frequency by red clover
Systematic reviews
Chen et al., 2019 [86] 15 RCT (9)
Prospective study (2)
Systematic review (2)
Randomized crossover trial (1)
Meta-analysis (2)
51–403 menopausal and postmenopausal women Soy (soy nut, soy protein, soy extracts)
Natural isoflavones
Synthetic isoflavones
Beneficial effects of isoflavones (vs. placebo)
Synthetic or combination of isoflavones more effective than natural soy
HRT more effective than soy or its extracts
Isoflavone in equol-producers or equol supplementation more effective than placebo.
Perna et al., 2016 [52] 7 RCT 40–403 menopausal and postmenopausal women Isoflavones 50–120 mg/day
Intervention period: 8 weeks–2 years
Reduction of hot flush frequency

HRT: hormone replacement therapy, RCT: randomized controlled trial, VSM: vasomotor symptoms.